Utama › Kanser Payudara › North Carolina › Durham
Kajian klinikal Kanser Payudara di Durham, NC
64 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Mengambil pesertaFasa 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- University of North Carolina, Chapel Hill · 10 mi jauh
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Mengambil pesertaFasa 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
Mengambil pesertaKajian pemerhatian
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Mengambil pesertaFasa 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of North Carolina, Chapel Hill · 10 mi jauh
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Mengambil pesertaFasa 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Mengambil pesertaFasa 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi jauh
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Mengambil pesertaFasa 2
- University of North Carolina Medical Center, Chapel Hill · 10 mi jauh
Identifying Patterns in the Breath of Individuals With Breast Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Mengambil pesertaFasa 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Mengambil pesertaFasa 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauh
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
Mengambil pesertaKajian pemerhatian
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Mengambil pesertaFasa 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Mengambil pesertaFasa 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Mengambil pesertaFasa 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi jauh
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Mengambil peserta
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
Mengambil pesertaKajian pemerhatian
- University of North Carolina, Chapel Hill · 10 mi jauh
Weight Management After Cancer for Survivors in Rural Communities
Mengambil peserta
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Mengambil peserta
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Mengambil pesertaFasa 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Mengambil peserta
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Mengambil pesertaFasa 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Mengambil peserta
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Mengambil pesertaFasa 1
- University of North Carolina, Chapel Hill · 10 mi jauh
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Mengambil peserta
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi jauh
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Mengambil peserta
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Mengambil pesertaKajian pemerhatian
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Mengambil pesertaFasa 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Mengambil pesertaFasa 1
- University of North Carolina, Chapel Hill · 10 mi jauh
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- The University of North Carolina, Chapel Hill · 10 mi jauh
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
Mengambil pesertaKajian pemerhatian
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Mengambil peserta
- University of North Carolina, Chapel Hill · 10 mi jauh
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Mengambil pesertaFasa 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauh
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Mengambil pesertaFasa 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Mengambil pesertaFasa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Mengambil peserta
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Mengambil pesertaFasa 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Mengambil pesertaKajian pemerhatian
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Mengambil peserta
- UNC Cancer Hospital, Chapel Hill · 10 mi jauh
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Mengambil peserta
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Mengambil peserta
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Mengambil peserta
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauh
BREAST Choice Decision Tool R21 - AIM2
Mengambil pesertaSukarelawan sihat dialu-alukan
- The University of North Carolina, Chapel Hill · 10 mi jauh
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Mengambil peserta
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauh
UNC Pleural Fluid Registry
Mengambil pesertaKajian pemerhatian
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
- Arlington, VA47 kajian
Kajian lain di Durham
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Metastatik33 kajian
- Kanser Prostat32 kajian
- Kanser Paru-paru32 kajian
- Kanser Kolorektal28 kajian
- Kanser Ovari27 kajian
- Leukemia Limfositik Kronik27 kajian
- Kegagalan Jantung26 kajian
- Kanser Pankreas24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.